Linden Thomas Advisory Services’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.59M Buy
72,846
+6,953
+11% +$274K 0.21% 153
2026
Q2
$3.06M Buy
65,893
+7,218
+12% +$260K 0.25% 124
2026
Q1
$1.44M Buy
58,675
+30,570
+109% +$724K 0.14% 258
2025
Q4
$697K Sell
28,105
-560
-2% -$14.9K 0.07% 358
2025
Q3
$813K Buy
28,665
+1,199
+4% +$32.5K 0.08% 334
2025
Q2
$683K Buy
27,466
+10,403
+61% +$293K 0.08% 357
2025
Q1
$529K Buy
17,063
+1,816
+12% +$60.5K 0.07% 368
2024
Q4
$481K Buy
15,247
+2,883
+23% +$137K 0.06% 387
2024
Q3
$716K Buy
12,364
+1,872
+18% +$92K 0.1% 324
2024
Q2
$426K Buy
10,492
+952
+10% +$37.8K 0.07% 374
2024
Q1
$401K Buy
9,540
+330
+4% +$12.9K 0.06% 378
2023
Q4
$353K Buy
9,210
+1,942
+27% +$64.7K 0.07% 361
2023
Q3
$224K Buy
7,268
+933
+15% +$32.2K 0.05% 370
2023
Q2
$200K Buy
+6,335
New +$217K 0.04% 357

Other funds holding ASTH

Linden Thomas Advisory Services's ASTH Position: Q3 2026 in Review

Linden Thomas Advisory Services increased its Astrana Health (ASTH) stake by 11% in Q3 2026, buying an estimated $274K and bringing the position to 72,846 shares worth $2.59M. The position accounts for 0.21% of the portfolio, ranked #153.

Linden Thomas Advisory Services first reported a position in ASTH in Q2 2023 and has held it in 14 quarters since. The position peaked at $3.06M in Q2 2026. 36 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Linden Thomas Advisory Services held 72,846 shares of Astrana Health worth $2.59M as of Q3 2026.
  • Linden Thomas Advisory Services bought 6,953 Astrana Health shares in Q3 2026, an estimated $274K.
  • Astrana Health made up 0.21% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #153 holding.
  • Linden Thomas Advisory Services first reported a position in Astrana Health in Q2 2023 and has held it in 14 quarters since.
  • Linden Thomas Advisory Services's Astrana Health position peaked at $3.06M in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.